Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 10;22(9):5047.
doi: 10.3390/ijms22095047.

Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review

Farha Ramzan  1 , Mark H Vickers  1 , Richard F Mithen  1
Affiliations
Review

Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review

Farha Ramzan et al. Int J Mol Sci. .

Abstract

Epigenetics refers to the DNA chemistry changes that result in the modification of gene transcription and translation independently of the underlying DNA coding sequence. Epigenetic modifications are reported to involve various molecular mechanisms, including classical epigenetic changes affecting DNA methylation and histone modifications and small RNA-mediated processes, particularly that of microRNAs. Epigenetic changes are reversible and are closely interconnected. They are recognised to play a critical role as mediators of gene regulation, and any alteration in these mechanisms has been identified to mediate various pathophysiological conditions. Moreover, genetic predisposition and environmental factors, including dietary alterations, lifestyle or metabolic status, are identified to interact with the human epigenome, highlighting the importance of epigenetic factors as underlying processes in the aetiology of various diseases such as MetS. This review will reflect on how both the classical and microRNA-regulated epigenetic changes are associated with the pathophysiology of metabolic syndrome. We will then focus on the various aspects of epigenetic-based strategies used to modify MetS outcomes, including epigenetic diet, epigenetic drugs, epigenome editing tools and miRNA-based therapies.

Keywords: DNA methylation; epigenetic diet; histone modification; microRNAs; prediabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Reddy K.S. Global Burden of Disease Study 2015 provides GPS for global health 2030. Lancet. 2016;388:1448–1449. doi: 10.1016/S0140-6736(16)31743-3. - DOI - PubMed
    1. Roth G.A., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A., et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7. - DOI - PMC - PubMed
    1. Alwan A. Global Status Report on Noncommunicable Diseases 2010. World Health Organization; Geneva, Switzerland: 2011. pp. 1–160.
    1. Ramzan F., D’Souza R.F., Durainayagam B.R., Milan A.M., Markworth J.F., Miranda-Soberanis V., Sequeira I.R., Roy N.C., Poppitt S.D., Mitchell C.J., et al. Circulatory miRNA biomarkers of metabolic syndrome. Acta Diabetol. 2020;57:203–214. doi: 10.1007/s00592-019-01406-6. - DOI - PubMed
    1. Vassallo P., Driver S.L., Stone N.J. Metabolic Syndrome: An Evolving Clinical Construct. Prog. Cardiovasc. Dis. 2016;59:172–177. doi: 10.1016/j.pcad.2016.07.012. - DOI - PubMed